Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

The Bard Venovo venous stent

Office-based cath lab setting proves safe for iliac vein stenting

Iliac vein stunting procedures performed in out-patient office-based labs are associated with low complication rates.

Polymer-free amphilimus-eluting stents comparable to drug-eluting stents—and offer a potential advantage

The team's evaluation included data from four different randomized controlled trials

quality excellence star stethoscope

Enrollment in ACC NCDR increased after U.S. News and World Report said it could improve hospital rankings

Even with this bump, only about one in three eligible hospitals participate in the NCDR registries. 

Surgeons Operating On Patient

TEE improves 30-day outcomes for patients undergoing cardiac valve or proximal aortic surgery

Intraoperative TEE, researchers wrote, can provide value during any open cardiac valve or proximal aortic surgery.

The Corvia Atrial Shunt is designed to address elevated left atrial pressure (LAP) heart failure patients.

Implantable atrial shunt therapy trial identifies treatable HFpEF patients

The REDUCE LAP-HF II study identified heart failure patients who may benefit from receiving a new transcatheter implant manufactured by Corvia Medical.

Continued anticoagulation after primary PCI boosts survival among STEMI patients

A key takeaway from the group's analysis was that the rate of major bleeding events did not significantly change. 

IVUS guidance during DES implantation boosts long-term outcomes

Researchers focused on data from two previous trials to track the impact of IVUS guidance on mortality rates and other key outcomes after three years. 

The Abbott Aveir DR dual-chamber leadless pacemaker recently had its first human implant occur in the Aveir DR i2i study pivotal trial.

First implant of dual-chamber leadless pacemaker completed in Abbott’s Aveir DR i2i pivotal trial

The investigational dual-chamber pacemaker is designed to provide synchronous, beat-by-beat pacing of the right atrium and right ventricle of the heart.

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.